Company: EpiVax/ Vaccine candidate: Ii-Key peptide vaccine Details: EpiVax is developing two Ii-Key peptide vaccine candidates against COVID-19. Status: EpiVax’s CEO said a vaccine could be ready within 5-6 months if the company receives the right level of funding.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.